COO
Cooper Companies, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website coopercos.com
- Employees(FY) 15000
- ISIN US2166485019
Performance
+2.18%
1W
-2.69%
1M
-2.58%
3M
+9.21%
6M
+8.87%
YTD
+21.78%
1Y
Profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Technical Analysis of COO 2024-12-02
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-02 13:29
- 2024-11-28 12:22
- 2024-11-26 19:00
COO: Raising target price to $108.00(Argus Research)
- 2024-11-12 19:00
COO: Lowering target price to $107.00(Argus Research)
- 2024-11-12 16:15
- 2024-11-12 03:15
- 2024-11-11 08:40
- 2024-11-05 19:00
COO: What does Argus have to say about COO?(Argus Research)
- 2024-10-30 08:10
What Makes The Cooper Companies (COO) a Strong Investment?(Insider Monkey)
- 2024-10-30 06:36
- 2024-10-08 20:00
COO: Lowering target price to $111.00(Argus Research)
- 2024-10-01 10:17
- 2024-09-27 10:51
- 2024-09-20 17:57
- 2024-09-20 08:31
- 2024-09-20 07:26
- 2024-09-19 12:00
- 2024-09-12 09:55
- 2024-09-11 04:28
- 2024-09-10 16:28
- 2024-09-10 08:27
- 2024-09-06 17:04
- 2024-09-06 12:45
- 2024-09-04 04:15
- 2024-09-03 16:15
- 2024-09-02 09:15
- 2024-08-30 06:56
- 2024-08-30 01:24
- 2024-08-29 18:35
Why Cooper Companies Stock Triumphed on Thursday(Motley Fool)
- 2024-08-29 13:21
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.